In trials involving 176 participants across four randomized controlled studies, liraglutide was used in 58% of cases (103 participants), while semaglutide was used in 13% (23 participants)
Recommendation: Intramuscular injection administered by a trained provider
Aerosol Sci
However, they should be evaluated by a healthcare professional if they persist, worsen, or if the area becomes hot to the touch
DED often manifests through telltale signs such as hazy vision, persistent dryness, and heightened sensitivity to light
discuss with a clinician regardless of provider) You want in-person care, frequent lab monitoring, or extensive clinical touch You are using GLP-1s to treat a diabetes indication specifically and need close coordination with primary care You find multi-month prepaid commitments uncomfortable without having seen the product quality first Your state has active enforcement against compounded GLP-1 shipments from out of state A pragmatic first-month approach: 1